摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Oxa-6,13,20-triazapentacyclo[12.8.0.03,12.05,10.016,21]docosa-5(10),6,8,11,13,17,19-heptaene

中文名称
——
中文别名
——
英文名称
2-Oxa-6,13,20-triazapentacyclo[12.8.0.03,12.05,10.016,21]docosa-5(10),6,8,11,13,17,19-heptaene
英文别名
2-oxa-6,13,20-triazapentacyclo[12.8.0.03,12.05,10.016,21]docosa-5(10),6,8,11,13,17,19-heptaene
2-Oxa-6,13,20-triazapentacyclo[12.8.0.03,12.05,10.016,21]docosa-5(10),6,8,11,13,17,19-heptaene化学式
CAS
——
化学式
C18H17N3O
mdl
——
分子量
291.3
InChiKey
SVAKGCSGJLTEAA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    22
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    46.8
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • [EN] NEW OCTAHYDRO-CYCLOBUTA [1,2-c;3,4-c']DIPYRROL-2-YL<br/>[FR] NOUVEL OCTAHYDRO-CYCLOBUTA [1,2-C; 3,4-C'] DIPYRROL-2-YL
    申请人:HOFFMANN LA ROCHE
    公开号:WO2015078803A1
    公开(公告)日:2015-06-04
    The invention provides novel compounds having the general formula (I) wherein R1, Y and R2 are as described herein, compositions including the compounds and methods of using the compounds.
    这项发明提供了具有一般式(I)的新化合物,其中R1、Y和R2如本文所述,包括这些化合物的组合物和使用这些化合物的方法。
  • [EN] PHENOXYMETHYL DERIVATIVES<br/>[FR] DÉRIVÉS DE PHÉNOXYMÉTHYLE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2017037146A1
    公开(公告)日:2017-03-09
    The invention provides novel compounds having the general formula (I), wherein RA, RB, RC, RC1 and W are as defined herein, compositions including the compounds and methods of using the compounds.
    这项发明提供了具有一般式(I)的新化合物,其中RA、RB、RC、RC1和W如本文所定义,包括这些化合物的组合物以及使用这些化合物的方法。
  • [EN] BICYCLIC COMPOUNDS AS AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION INHIBITORS<br/>[FR] COMPOSÉS BICYCLIQUES EN TANT QU'INHIBITEURS DE PRODUCTION D'AUTOTAXINE (ATX) ET D'ACIDE LYSOPHOSPHATIDIQUE (LPA)
    申请人:HOFFMANN LA ROCHE
    公开号:WO2015144605A1
    公开(公告)日:2015-10-01
    The invention provides novel compounds having the general formula (I) wherein R1, R2, A, W, m, n, p and q are as described herein, compositions including the compounds. The compounds of formula (I) are useful as autotaxin (ATX) inhibitors which are inhibitors of lysophosphatidic acid (LPA) production and thus modulators of LPA levels and associated signaling; in particular they are useful for the treatment or prophylaxis of renal conditions, liver conditions, inflammatory conditions, conditions of the nervous system, conditions of the respiratory system, vascular and cardiovascular conditions, fibrotic diseases, cancer, ocular conditions, metabolic conditions, cholestatic and other forms of chronic pruritus and acute and chronic organ transplant rejection.
    该发明提供了具有通式(I)的新化合物,其中R1、R2、A、W、m、n、p和q如本文所述,包括这些化合物的组合物。通式(I)的化合物可用作自体税肽酶(ATX)抑制剂,这些抑制剂是溶磷脂酸(LPA)产生的抑制剂,从而调节LPA平和相关信号传导;特别是它们可用于治疗或预防肾脏疾病、肝脏疾病、炎症性疾病、神经系统疾病、呼吸系统疾病、血管和心血管疾病、纤维化疾病、癌症、眼部疾病、代谢性疾病、胆汁淤积和其他形式的慢性瘙痒以及急性和慢性器官移植排斥反应的治疗。
  • [EN] HETEROCYCLIC COMPOUNDS USEFUL AS DUAL ATX/CA INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILES EN TANT QU'INHIBITEURS DOUBLES D'ATX/CA
    申请人:HOFFMANN LA ROCHE
    公开号:WO2018167001A1
    公开(公告)日:2018-09-20
    The invention provides novel compounds having the general formula (I) wherein R1 is selected from substituted phenyl, pyridinyl or thiophenyl, R2 is selected from optionally substituted aminosulphonylphenyl, aminosulphonylpyridinyl, aminosulphonylthiophenyl or aminosulphonylthiazolyl, X is nitrogen or carbon, Y is a linking group, Z is a direct bond or a linking group, m = 0-5, n = 0-5 with the proviso that m+n is 2-5, compositions including the compounds and the use of the compounds in the treatment or prophylaxis of ocular conditions.
    该发明提供了具有一般式(I)的新化合物,其中R1选自取代苯基、吡啶基或噻吩基,R2选自可选择取代的基磺酰基苯基、基磺酰基吡啶基、基磺酰基噻吩基或基磺酰基噻唑基,X为氮或碳,Y为连接基,Z为直接键或连接基,m = 0-5,n = 0-5,但m + n为2-5,包括这些化合物的组合物以及这些化合物在治疗或预防眼部疾病中的用途。
  • [EN] NEW BICYCLIC COMPOUNDS AS ATX INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS BICYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS D'ATX
    申请人:HOFFMANN LA ROCHE
    公开号:WO2018167113A1
    公开(公告)日:2018-09-20
    The invention provides novel compounds having the general formulas (I), (II), wherein R1, R2, Y, W, A, X, m and n are as defined herein, compositions including the compounds and methods of using the compounds.
    这项发明提供了具有一般式(I)、(II)的新化合物,其中R1、R2、Y、W、A、X、m和n的定义如本文所述,包括这些化合物的组合物和使用这些化合物的方法。
查看更多